Neuroscience and Medicine

Neuroscience and Medicine

ISSN Print: 2158-2912
ISSN Online: 2158-2947
www.scirp.org/journal/nm
E-mail: nm@scirp.org
"Effects of Ginkgo Biloba Special Extract EGb 761® in Very Mild Cognitive Impairment (vMCI)"
written by Brigitte Grass-Kapanke, Arija Busmane, Andris Lasmanis, Robert Hoerr, Reiner Kaschel,
published by Neuroscience and Medicine, Vol.2 No.1, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] BrainCheck
[2] Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
2021
[3] New therapeutic approaches to mild cognitive impairment and mild dementia: the role of Ginkgo Biloba (EGb 761®)
2021
[4] Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)
2021
[5] Management of mild cognitive impairment (MCI): The need for national and international guidelines
2020
[6] Stability studies of hydralazine hydrochloride orodispersible formulations
2020
[7] Prüfplan für die monozentrische prospektive randomisierte placebokontrollierte doppelblinde Phase-II-Studie zur Exploration protektiver Effekte des Ginkgo-biloba …
2020
[8] Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
Pathology, Prevention and Therapeutics of Neurodegenerative Disease, 2019
[9] Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
2019
[10] Cognitive enhancement effect of Ginkgo biloba extract on memory and learning impairments induced by fluoride neurotoxicity
2019
[11] Mitochondria-and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
2019
[12] PLANT-DERIVED PHYTOCHEMICALS TO ENHANCE COGNITIVE FUNCTION AND ALERTNESS
2019
[13] Cognitive impairment in anxiety disorders
2018
[14] Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence
2018
[15] Phytochemicals for improving aspects of cognitive function and psychological state potentially relevant to sports performance
2018
[16] Когнитивные нарушения при тревожных расстройствах
2018
[17] INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES
2018
[18] Cognitive impairment without dementia: A current view of the problem
2017
[19] Когнитивные жалобы и нарушения у пациентов с хронической ежедневной головной болью
2017
[20] Cognitive complaints and cognitive impairment in patients with chronic daily headache
2017
[21] Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer's disease
Mechanics of Advanced Materials and Structures, 2017
[22] Недементные когнитивные нарушения: современный взгляд на проблему
2017
[23] Лечение комбинированных когнитивных и эмоциональных расстройств у больных молодого и среднего возраста
2016
[24] Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment–a randomized double‐blind placebo‐controlled trial
Human Psychopharmacology: Clinical and Experimental, 2016
[25] An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
Frontiers in aging neuroscience, 2016
[26] Treatment for mixed cognitive impairments and emotional disorders in young and middle-aged patients
2016
[27] Bioactive dietary compounds regulate mitochondrial apoptosis signaling in ambivalent way to function as neuroprotective or antitumor agents
Studies in Natural Products Chemistry, 2016
[28] Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective …
Human Psychopharmacology: Clinical and Experimental, 2016
[29] Ginkgo biloba and Usage in Dementia: From Eastern Tradition to Western Science
Diet and Nutrition in Dementia and Cognitive Decline, 2015
[30] A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761®
European archives of psychiatry and clinical neuroscience, 2015
[31] Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
The journal of nutrition, health & aging, 2015
[32] Efficacy and safety of Ginkgo biloba extract EGb 761? in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind, multi‐center trial
International journal of geriatric psychiatry, 2014
[33] Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled …
International journal of geriatric psychiatry, 2014
[34] Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind …
2014
[35] Ginkgo biloba Extract EGb 761?: From an Ancient Asian Plant to a Modern European Herbal Medicinal Product
Evidence and Rational Based Research on Chinese Drugs. Springer Vienna, 2013
[36] Is Ginkgo biloba Safe?
life-enhancement, 2013
[37] Применение мемопланта (EGb 761) в неврологической практике
МЕМОПЛАНТ В НЕВРОЛОГИИ, 2013
[38] Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat …
International Psychogeriatrics, 2012
[39] Ginkgo biloba leaf extract (EGb 761?) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761?
International Psychogeriatrics, 2012
[40] Clinical data in early intervention
International Psychogeriatrics, 2012
[41] Gait, mobility, and falls in older people
University Library of Basel, 2012
[42] Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex …
2012
[43] Ginkgo biloba leaf extract (EGb 761R ) and its speci?c acylated ?avonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761
International Psychogeriatrics, 2012
[44] Frühe Intervention gefordert. Evidenz für Ginkgo biloba in der Demenz-Therapie
Schattauer, 2012
[45] Gruppo Farmaimpresa Product & consulting
[46] Psychophysische Erschöpfung
Free SCIRP Newsletters
Copyright © 2006-2022 Scientific Research Publishing Inc. All Rights Reserved.
Top